The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?

Am J Law Med. 1999;25(4):543-68.
No abstract available

MeSH terms

  • Drug Approval / legislation & jurisprudence*
  • Drug Industry / legislation & jurisprudence
  • Drug Industry / standards*
  • Humans
  • Investigational New Drug Application / legislation & jurisprudence
  • Liability, Legal
  • Terminally Ill
  • Time Factors
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • United States Food and Drug Administration / standards*